Ilenia Calcaterra: From Representation to Intellectual Independence in Women in Science
Ilenia (Lorenza) Calcaterra, Consultant Physician in Internal Medicine and Assistant Professor at the University of Naples Federico II, shared Thieme International’s post on LinkedIn, adding:
“Honored to contribute to the Women in Science initiative.
Coming from a cultural context where female academic leadership is still underrepresented, I learned early that autonomy is not granted, it is built.
But this conversation is not local. It is global.
Across countries and systems, the real challenge is not only representation, but intellectual independence: the ability to think rigorously, to lead responsibly, and to occupy space with competence.
I believe international dialogue is essential.
We grow not by celebrating visibility alone, but by exchanging perspectives, questioning assumptions, and strengthening standards together.
I would be genuinely interested in hearing how female leadership in science is evolving in different academic contexts.”
Quoting Thieme International’s post:
“Dr. Ilenia Calcaterra, is a Consultant Physician in Internal Medicine and Assistant Professor at the University of Naples ‘Federico II.’
She graduated with honors in Medicine and Surgery, completed her specialization in Internal Medicine, and earned a PhD in Advanced Biomedical and Surgical Therapies.
Her clinical and research activity focuses on cardiovascular prevention, dyslipidemias, atherothrombosis, and congenital bleeding disorders, with particular expertise in hemophilia and innovative therapeutic approaches, including gene therapy. She has authored more than 50 peer-reviewed publications in international journals and is actively involved in multinational clinical trials and translational research projects.
Her work integrates patient care, advanced vascular imaging, and precision medicine, aiming to translate scientific evidence into improved clinical outcomes. Alongside her research activity, she is engaged in academic teaching and mentorship, supporting medical students and young physicians in their professional growth.
The value and visibility of women in science have been a meaningful reference throughout her professional path. She believes that sharing experiences and achievements can help foster confidence and opportunities for the next generation of women in medicine.”
Title: Emicizumab in Acquired Hemophilia A: A Real-World Case Series with Patient-Level Outcome Analysis
Author: Ilenia Calcaterra, Carmine De Luca, Guido D’Errico, Ciro Miele, Chiara Caputo, Raffaele Russo, Paolo Conca, Ernesto Cimino, Anna Guida, Antonella Tufano, Matteo Di Minno
Read the Full Article on Seminars in Thrombosis and Hemostasis.

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026